Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice. - Wikidata - wikimedia - TriplyDB

Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.

Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.

http://www.wikidata.org/entity/Q42621245

about

Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model The Eye As a Biomarker for Alzheimer's Disease Ocular indicators of Alzheimer's: exploring disease in the retina The role of optical coherence tomography in Alzheimer's disease Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice.Suppressed retinal degeneration in aged wild type and APPswe/PS1ΔE9 mice by bone marrow transplantation Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.Endoplasmic reticulum stress promotes amyloid-beta peptides production in RGC-5 cells.A new glaucoma hypothesis: a role of glymphatic system dysfunction.Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer's Disease.Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis Alzheimer's Disease-Related Protein Expression in the Retina of Octodon degus Cyclic intensive light exposure induces retinal lesions similar to age-related macular degeneration in APPswe/PS1 bigenic mice Ocular manifestations of Alzheimer's disease in animal models.Retinal nerve fibre layer thinning is associated with drug resistance in epilepsy.Ocular changes in TgF344-AD rat model of Alzheimer's disease.Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.The retina as a window to the brain-from eye research to CNS disorders.Review: tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain?Retinal manifestations of Alzheimer's disease.How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis?Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.Glymphatic stasis at the site of the lamina cribrosa as a potential mechanism underlying open-angle glaucoma.Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.Emerging ocular biomarkers of Alzheimer disease.The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma.Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases.Amyloid-beta, the retina, and mouse models of Alzheimer disease.Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice.Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.Can the retina be used to diagnose and plot the progression of Alzheimer's disease?Characterisation of amyloid-induced inflammatory responses in the rat retina.Inhibition of PTEN Attenuates Endoplasmic Reticulum Stress and Apoptosis via Activation of PI3K/AKT Pathway in Alzheimer's Disease.

P2860

Q26752621-B9A56526-898A-406A-AA21-BB0547E7E7D6 Q27316689-CE75E96D-56BB-4F23-8224-C4897E7A5286 Q28070142-41785AB2-5C60-4547-9415-0E8825B3C37D Q28078670-76C3D9A0-8110-46CC-936B-CFB376502ACA Q28079500-16C09BF5-D57C-4600-B45C-62BA04956D55 Q34135059-348DB8C4-4FDD-4EF4-9D8C-D982B3426EDE Q34193337-CB30C208-2931-493F-89B2-038967F7DE22 Q34245979-B53C51AF-161E-43B9-A1A2-273142E8DE1F Q34541965-F843117D-32F3-40C0-892E-60217C12C3C8 Q34764098-DDE5DFB2-87A3-401F-B513-AAC635C95D5E Q35095392-9DE3FCA2-D7C2-4D71-9BFD-7566EDA5221F Q35319462-99F9F20B-5EB5-4BA6-8754-13338B8B132D Q35676531-2E183AD9-5FBE-46EB-B4AD-9E90F63BE46A Q35708602-0F8AA910-E0C9-44ED-BCAA-E9D0ABEE316F Q35740076-D45749E3-A6AA-41C8-84B1-CADFD6360918 Q35743990-39834D34-6DDE-42FC-A7DE-F380784DB979 Q35917824-0244A5F6-01E6-4739-905E-9BB5B8FC0FFB Q35993835-0B620759-24A2-4F54-A730-2F9C07452D00 Q36762059-8DF6A0A6-BE97-4755-B2C2-C80D109E18EB Q37533199-595048F0-E1BB-4EEF-B647-C0A582E65F96 Q37874157-5FE6AC74-A5F5-4767-A3F3-94D604D8D094 Q37985523-501BE291-880F-4E96-B7AB-3DEA7EA16366 Q38061012-429D6CF4-BD80-4CB1-A05A-2112F2DAFAAF Q38061419-A9FC4F3E-3A73-450E-9F6A-777418F82F20 Q38237224-8641CC1F-F177-4FD1-985E-AA9809D4A412 Q38580403-897159FE-E9F5-4B9B-B6DD-5BE866845A76 Q38642869-86884626-735F-415D-9B61-2111502D4B2B Q38873518-775C5D62-D5FA-44DC-9ACD-849BBBCD32F9 Q38994972-831822E2-A24A-4427-AA44-6E6185DC5AB1 Q39091275-B52ECD77-2798-449D-9D5B-D8445867EFFE Q39113804-33896289-6EAE-40FB-9FD5-4C6CBCF13BC4 Q39449147-1D627792-CB89-465A-966B-136830D04916 Q41845723-384C60AC-8A0D-4EAB-A185-DAB5B24639AC Q42355513-5BE9CDC4-63D9-4177-9284-0D089AD54156 Q42861634-190722B7-A695-4DCD-8FE3-FEAB7190B90A Q44836303-CDDEE508-742C-4539-8190-48E45C86B7E3 Q47221811-03A4726E-4139-4705-B921-5550D01348C2 Q47315641-D3053717-0C25-40F9-A156-5167C8B09DA0 Q47579780-621FD922-05B3-487A-9ABE-4F244A888661 Q47936640-811646EF-0994-4B98-8C47-EA730E0CEBF9

P2860

Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.

http://www.wikidata.org/entity/Q42621245

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Amyloid-peptide vaccinations r ...... f Alzheimer's transgenic mice.

@en

Amyloid-peptide vaccinations r ...... f Alzheimer's transgenic mice.

@nl

type

label

Amyloid-peptide vaccinations r ...... f Alzheimer's transgenic mice.

@en

Amyloid-peptide vaccinations r ...... f Alzheimer's transgenic mice.

@nl

prefLabel

Amyloid-peptide vaccinations r ...... f Alzheimer's transgenic mice.

@en

Amyloid-peptide vaccinations r ...... f Alzheimer's transgenic mice.

@nl

P1433

Q42621245-538FECD0-ECD1-4769-90C8-E93067BFA8EC

P1476

Q42621245-065FB239-38BA-4287-B432-60F5AC879EA8

P2093

Q42621245-0108A7EB-402A-48B1-9728-0EAEFA7F8C06

Q42621245-2C150EB7-665C-440C-94D8-CE361895F121

Q42621245-2D8A1B8C-EE56-4F20-A8B9-358903FCCC95

Q42621245-45BE26A2-1E2B-4855-A1F6-E9861A4FC0EC

Q42621245-49C0D615-7321-4235-94AB-FBF305B82ECE

Q42621245-70BA070B-A3B0-4622-887F-74210E1678D0

Q42621245-FCD3989E-6732-4CE5-B591-7FD425D61E3A

P2860

Q42621245-00FC73AA-6C7B-47B0-A35D-9FE5DAF4BA43

Q42621245-033A0940-C795-46FE-A8DD-2EC5A76832B2

Q42621245-05429FC3-5347-41FF-B5BB-3AE99C8D8398

Q42621245-0E471A52-B77A-49BE-9337-DAAF4C474876

Q42621245-1352B124-D71C-4F41-BA36-13167C5ACBE4

Q42621245-16CC65BC-F93B-4F4E-B4ED-568477C75EFA

Q42621245-24569054-CA87-4AB0-8508-DE2A14AF8812

Q42621245-26B602D7-48FC-4D6E-9DE1-F10864D31B17

Q42621245-2800B584-889A-4552-AA24-5BD6F181C6FE

Q42621245-28CA6F9E-0463-4CE4-A224-6891AE6F6931

P304

Q42621245-2D84526B-0243-4444-A4E7-13EF64973AD3

P31

Q42621245-75EC4474-6917-4BA3-A1BC-03DAEE0C7931

P356

Q42621245-6721DFAD-9CB1-42D3-9016-FA9821891D96

P407

Q42621245-D592A862-EA19-4422-ADD2-8908F288E69D

P433

Q42621245-4A2161EB-BFB0-4A5F-9652-42F20924775C

P478

Q42621245-A191861E-2833-4F0B-9E5B-D8C906BA5834

P577

Q42621245-107E1FE8-7D40-4E77-A69D-0D829EBDA497

P5875

Q42621245-6735721A-C002-4BD6-8654-4D54D1D254D8

P698

Q42621245-5B15E60B-772F-45C9-9287-4B9C4A218053

P921

Q42621245-36E729EB-5D37-4BA3-B5E2-8E5BC6D73D11

P932

Q42621245-C1E8DA79-98D2-41E3-844C-02B405D87EF9

P356

AJPATH.2009.090159

P1433

The American Journal of Pathology

P1476

Amyloid-peptide vaccinations r ...... f Alzheimer's transgenic mice.

@en

P2093

Bingqian Liu

http://www.w3.org/2001/XMLSchema#string

Charles G Glabe

http://www.w3.org/2001/XMLSchema#string

Jian Ge

http://www.w3.org/2001/XMLSchema#string

Steven S Schreiber

http://www.w3.org/2001/XMLSchema#string

Suhail Rasool

http://www.w3.org/2001/XMLSchema#string

Zhikuan Yang

http://www.w3.org/2001/XMLSchema#string

Zhiqun Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Pathways towards and away from Alzheimer's disease

Novel Abeta peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease.

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Microglia-specific localisation of a novel calcium binding protein, Iba1

Immunohistochemical study of p53-associated proteins in rat brain following lithium-pilocarpine status epilepticus

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.

Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.

Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

P304

2099-2110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2009.090159

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

175

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38015326

http://www.w3.org/2001/XMLSchema#string

P698

19834067

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2774073

http://www.w3.org/2001/XMLSchema#string